The Global Breast Lesion Localization Methods Market was valued at US$ 323.43 million in 2015 and is projected to expand at a CAGR of 11.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Increasing number of patients suffering from breast cancer globally is projected to support growth of the breast lesion localization methods market over the forecast period.

Growing development of advanced imaging systems and its use globally are favoring increase in number of surgeries for non-palpable invasive and pre-invasive lesions, as surgeons are now more confident about effective diagnosis and detection of precise location of the tumor. This in turn is projected to support the growth in breast lesion localization methods market over the forecast period. Furthermore, such screening techniques have led to early detection in breast cancer conditions and thus, allow for more effective treatment of the disorder. Advanced imaging systems allow for precise localization of the occult lesion clinically and help prevent any loss to other tissues around the affected mass. These also allow performing breast conserving surgery for better cosmetic outcome. These factors make such systems a preferred choice among users and thus, would fuel the growth of breast lesion localization methods market over the forecast period.

Government regulations and current guidelines implemented in order to maintain women’s health and also to minimize the prevalence of breast cancer, creates a highly conducive environment for breast lesion localization methods market growth in the near future. According to Centers for Disease Control, in 2000, the authority itself funded the National Breast and Cervical Early Detection Program in all states such as the District of Columbia, along with six U.S. territories, and 12 American Indian/Alaska native organizations

To know the latest trends and insights prevalent in the global breast lesion localization methods market, click the link below:

https://www.coherentmarketinsights.com/market-insight/breast-lesion-localization-methods-market-104

Breast cancer is one of the most prevalent cancer worldwide with an estimated ratio of indirect to direct cost approximately amounting to 3:1. According to U.S. Centers for Disease Control and Prevention, an adult woman (18 -29 years age group) in the U.S. spends US$ 19,435 more on medical care per year than one without breast cancer. Increasing incidence of breast cancer would further augment market growth. New cost-effective methods have been introduced that are expected to support growth in adoption rate for breast lesion localization method in the near future

For instance, according to Xconomy, Inc., in 2017, Elucent Medical, a newly formed organization, raised around US$ 7.0 Mn for development of breast cancer medical devices and to enrich its product portfolio. Industry players are constantly working towards enhancing their product portfolio in order to sustain in the market. This further accelerates growth of the breast lesion localization methods market. Also, increase in healthcare expenditure by local governments has backed up the growth in healthcare infrastructure, primarily in emerging economies on the backdrop of low manufacturing cost and regulations. Also, many regional companies have emerged in India and ASEAN, owing to changing economic profile and favorable government initiatives such as Make in India campaign by the Indian government.

Major market players are laying emphasis on product development, upgrading existing devices, and inorganic growth through various strategic mergers and acquisitions. For instance, in 2016, AbbVie – a global biopharmaceutical company – acquired Stemcentrx, which has four novel compounds under clinical trials for solid tumor indications that further includes triple negative breast cancer, ovarian cancer and non-small cell lung cancer

Key takeaways of the market:

• The global breast lesion localization methods market is expected to expand at a CAGR of 11.0% during the forecast period (2016–2024). Technological advancements in screening methods are favoring demand for non-palpable invasive surgeries that is expected to favor the market for breast lesion localization methods over the forecast period.
• The wire guided localization segment was estimated to be the largest in 2015 and is expected to retain its dominance in the market throughout the forecast period in terms of value closely followed by radio guided occult lesion localization. Rise in prevalence for breast cancer globally is projected to support the growth for the market in the near future.
• In terms of end user segment, the hospitals end user segment is expected to expand at a significant CAGR of 12.1% during the forecast period, owing to more advanced in terms of infrastructural installations of medical systems
• The global breast lesion localization methods market is characterized by strategic research and development and advancements in the methods for localization under various medical devices.
• Some of the major players in the global breast lesion localization methods market are Cook Medical Inc., Argon Medical Devices, Inc, C. R. Bard, Inc., SOMATEX Medical Technologies GmbH, Tsunami S.r.l, Sterylab Medical and Biopsybell Srl.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]